Nhung Viet Nguyen
Overview
Explore the profile of Nhung Viet Nguyen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaur P, Chaisson L, Kiragu Z, Buddadhumaruk P, Austin A, Gao Y, et al.
Contemp Clin Trials
. 2025 Mar;
152:107875.
PMID: 40064371
Background: Current guidelines for the treatment of multidrug-resistant/rifampin-resistant tuberculosis (MDR/RR-TB) are based on clinical trials evaluating fixed duration regimens. However, when a regimen succeeds, it remains unknown whether a shorter...
2.
C-Reactive Protein-based Screening of People with Tuberculosis Symptoms: A Diagnostic Accuracy Study
Derendinger B, Mochizuki T, Marcelo D, Shankar D, Mangeni W, Nguyen H, et al.
Am J Respir Crit Care Med
. 2024 Dec;
211(3):499-506.
PMID: 39642368
C-reactive protein (CRP)-based tuberculosis (TB) screening is recommended for people with HIV. However, its performance among people without HIV and in diverse settings is unknown. In a multicountry study, we...
3.
Sossen B, Szekely R, Mukoka M, Muyoyeta M, Nakabugo E, Hella J, et al.
Lancet Glob Health
. 2024 Nov;
12(12):e2024-2034.
PMID: 39577975
Background: Diagnostic delays for tuberculosis are common, with high resultant mortality. Urine-Xpert Ultra (Cepheid) could improve time to diagnosis of tuberculosis disease and rifampicin resistance. We previously reported on lot-to-lot...
4.
Gils T, Hella J, Jacobs B, Sossen B, Mukoka M, Muyoyeta M, et al.
J Infect Dis
. 2024 Jul;
231(1):e82-e90.
PMID: 39046150
Background: CD4 measurement is pivotal in the management of advanced human immunodeficiency virus (HIV) disease. VISITECT CD4 Advanced Disease (VISITECT; AccuBio, Ltd) is an instrument-free, point-of-care, semiquantitative test allowing visual...
5.
Szekely R, Sossen B, Mukoka M, Muyoyeta M, Nakabugo E, Hella J, et al.
PLoS One
. 2024 May;
19(5):e0303846.
PMID: 38820372
There is an urgent need for rapid, non-sputum point-of-care diagnostics to detect tuberculosis. This prospective trial in seven high tuberculosis burden countries evaluated the diagnostic accuracy of the point-of-care urine-based...
6.
Derendinger B, Mochizuki T, Marcelo D, Shankar D, Mangeni W, Nguyen H, et al.
medRxiv
. 2024 May;
PMID: 38712173
Rationale: C-reactive protein (CRP)-based tuberculosis (TB) screening is recommended for people with HIV (PWH). However, its performance among people without HIV and in diverse settings is unknown. Objectives: In a...
7.
Van Nguyen H, Nguyen H, Ha D, Thi Huong D, Ngoc Trung V, Thi Thuy Ngoc K, et al.
J Clin Tuberc Other Mycobact Dis
. 2024 Mar;
35:100431.
PMID: 38523706
Objective: We conducted a descriptive analysis of multi-drug resistant tuberculosis (MDR-TB) in Vietnam's two largest cities, Hanoi and Ho Chi Minh city. Methods: All patients with rifampicin resistant tuberculosis were...
8.
Forse R, Nguyen T, Dam T, Vo L, Codlin A, Caws M, et al.
PLOS Glob Public Health
. 2023 Dec;
3(12):e0002439.
PMID: 38055709
To achieve the Sustainable Development Goal's targets of universal health coverage (UHC) and poverty reduction, interventions are required that strengthen and harmonize both UHC and social protection. Vietnam is committed...
9.
Pham T, Forse R, Codlin A, Phan T, Nguyen T, Nguyen N, et al.
BMC Public Health
. 2023 Dec;
23(1):2372.
PMID: 38042797
Background: Globally, most people with multidrug-resistant tuberculosis (MDR-TB) and their households experience catastrophic costs of illness, diagnosis, and care. However, the factors associated with experiencing catastrophic costs are poorly understood....
10.
Vo L, Tran T, Pham H, Nguyen H, Doan H, Truong H, et al.
Sci Rep
. 2023 Sep;
13(1):15209.
PMID: 37709844
Current WHO-recommended diagnostic tools for tuberculosis infection (TBI) have well-known limitations and viable alternatives are urgently needed. We compared the diagnostic performance and accuracy of the novel QIAreach QuantiFERON-TB assay...